Wiley Bros.-aintree Capital »

Emergent BioSolutions shares owned by Wiley Bros.-aintree Capital

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Wiley Bros.-aintree Capital from 13F filings

Historical chart of Wiley Bros.-aintree Capital investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Wiley Bros.-aintree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Wiley Bros.-aintree Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $149k 18k 8.38
2026-03-31 $145k 17k 8.30
2025-12-31 $210k 17k 12.36

More positions owned by Wiley Bros.-aintree Capital

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Micron Technology (MU)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wiley Bros.-aintree Capital

Top funds holding Emergent BioSolutions

BlackRock
Dimensional Fund Advisors
State Street Corporation
American Century Companies
Vanguard Capital Management
LSV Asset Management
Acadian Asset Management
Geode Capital Management
Charles Schwab Investment Management
Sixth Street Partners Management Company
Oak Hill Advisors
Millennium Management
Ancora Advisors
AQR Capital Management
Goldman Sachs Group

View all funds holding Emergent BioSolutions